| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.005 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |